指南与共识肝病消化道肿瘤与早癌

肝细胞癌的过度诊断:能否通过指南预防?

Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?
指南 / 共识 · Hepatology · 2022-01-18

本文讨论肝细胞癌监测项目中过度诊断的定义、常见原因(诊断标准不准确、检出癌前或极早期恶性病变、惰性肿瘤、竞争性死亡风险)及负性后果(过度治疗、经济毒性、心理伤害)。指南推荐(高危人群定义、监测方法、间隔、召回流程、诊断标准)可部分但非完全降低过度诊断风险,仍需进一步研究以明确其负担、趋势及减少策略。

要点

  • 过度诊断指检出患者终生不会出现临床症状的疾病,在肝细胞癌监测中已有报道但研究较少。
  • 过度诊断可导致过度治疗及相关并发症、经济毒性和心理伤害。
  • 指南推荐(高危人群定义、监测方法、间隔、召回流程、诊断标准)可部分降低但未消除过度诊断风险。

核心结论

  • 指南推荐可部分降低但未消除肝细胞癌监测中的过度诊断风险,仍需进一步研究以明确其负担、趋势并制定减少策略。

研究设计与样本

  • 本文为指南类文章,讨论肝细胞癌监测中过度诊断的定义、原因、后果及指南推荐对过度诊断风险的影响。

主要发现

  • 过度诊断在多种癌症中常见,但描述其在肝细胞癌监测项目中患病率的研究较少。
  • 过度诊断可导致过度治疗及相关并发症、经济毒性和心理伤害。
  • 过度诊断的原因包括诊断标准不准确、检出癌前或极早期恶性病变、检出惰性肿瘤以及竞争性死亡风险。

关键数值与推荐

  • 指南推荐涉及监测人群的定义、监测方法、监测间隔、召回流程和肝细胞癌诊断标准,这些推荐可部分降低但未消除过度诊断风险。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Overdiagnosis refers to detection of disease that would not otherwise become clinically apparent during a patient's lifetime. Overdiagnosis is common and has been reported for several cancer types, although there are few studies describing its prevalence in HCC surveillance programs. Overdiagnosis can have serious negative consequences including overtreatment and associated complications, financial toxicity, and psychological harms related to being labeled with a cancer diagnosis. Overdiagnosis can occur for several different reasons including inaccurate diagnostic criteria, detection of premalignant or very early malignant lesions, detection of indolent tumors, and competing risks of mortality. The risk of overdiagnosis is partly mitigated, albeit not eliminated, by several guideline recommendations, including definitions for the at-risk population in whom surveillance should be performed, surveillance modalities, surveillance interval, recall procedures, and HCC diagnostic criteria. Continued research is needed to further characterize the burden and trends of overdiagnosis as well as identify strategies to reduce overdiagnosis in the future.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Rich NE, Singal AG. Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines? Hepatology. 2022. PMID: 34923659. doi:10.1002/hep.32284

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。